Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Campbell

Showing results (31-40 of 240) with videos related to

Pageof 24
Sort By:
Expert Review of Clinical Immunology|August 22, 2014
IL-18: a new player in immunotherapy for age-related macular degeneration?Matthew Campbell, Sarah Doyle, Peter Humphries
Therapeutic Delivery|July 25, 2012
From RNA interference technology to effective therapy: how far have we come and how far to go?James Keaney, Matthew Campbell, Peter Humphries
Journal of Clinical Medicine|August 4, 2015
NLRP3 Inflammasome and Pathobiology in AMDLucia Celkova, Sarah L Doyle, Matthew Campbell
Clinical Pediatrics|June 11, 2019
With a High, Comes a Low: A Case of Heavy Marijuana Use and Bradycardia in an AdolescentAnita Chaphekar, Matthew Campbell, Amy B Middleman
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Barrier modulation in drug delivery to the retinaMatthew Campbell, Marian M Humphries, Peter Humphries
Journal of Inflammation Research|February 6, 2015
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectivesEma Ozaki, Matthew Campbell, Sarah L Doyle
Current Opinion in Pediatrics|December 19, 2024
Advances in cellular therapies for children and young adults with solid tumorsMichelle Choe, Matthew Campbell, Catherine M Albert
Pediatric Research|May 23, 2025
Fishing for a solution: exploring the impact of omega 3 supplement use in childhood obesityMatthew Campbell, Phillip Nehls, Jeanie B Tryggestad
Fluids and Barriers of the CNS|March 28, 2023
The CLDN5 gene at the blood-brain barrier in health and diseaseYosuke Hashimoto, Chris Greene, Arnold Munnich, et al.
International Journal of Molecular Sciences|January 2, 2020
Tight Junctions of the Outer Blood Retina BarrierAisling Naylor, Alan Hopkins, Natalie Hudson, et al.
Pageof 24

Showing results (31-40 of 240) with videos related to

Sort By:
Pageof 24
Expert Review of Clinical Immunology|August 22, 2014
IL-18: a new player in immunotherapy for age-related macular degeneration?Matthew Campbell, Sarah Doyle, Peter Humphries
Therapeutic Delivery|July 25, 2012
From RNA interference technology to effective therapy: how far have we come and how far to go?James Keaney, Matthew Campbell, Peter Humphries
Journal of Clinical Medicine|August 4, 2015
NLRP3 Inflammasome and Pathobiology in AMDLucia Celkova, Sarah L Doyle, Matthew Campbell
Clinical Pediatrics|June 11, 2019
With a High, Comes a Low: A Case of Heavy Marijuana Use and Bradycardia in an AdolescentAnita Chaphekar, Matthew Campbell, Amy B Middleman
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Barrier modulation in drug delivery to the retinaMatthew Campbell, Marian M Humphries, Peter Humphries
Journal of Inflammation Research|February 6, 2015
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectivesEma Ozaki, Matthew Campbell, Sarah L Doyle
Current Opinion in Pediatrics|December 19, 2024
Advances in cellular therapies for children and young adults with solid tumorsMichelle Choe, Matthew Campbell, Catherine M Albert
Pediatric Research|May 23, 2025
Fishing for a solution: exploring the impact of omega 3 supplement use in childhood obesityMatthew Campbell, Phillip Nehls, Jeanie B Tryggestad
Fluids and Barriers of the CNS|March 28, 2023
The CLDN5 gene at the blood-brain barrier in health and diseaseYosuke Hashimoto, Chris Greene, Arnold Munnich, et al.
International Journal of Molecular Sciences|January 2, 2020
Tight Junctions of the Outer Blood Retina BarrierAisling Naylor, Alan Hopkins, Natalie Hudson, et al.
Pageof 24